Log In
BCIQ
Print this Print this
 

ASP7147

  Manage Alerts
Collapse Summary General Information
Company Seldar Pharma Inc.
DescriptionGastrin-releasing peptide receptor (GRP-R; BB2) antagonist
Molecular Target Gastrin-releasing peptide receptor (GRP-R) (BB2)
Mechanism of ActionGastrin-releasing peptide receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD)
Regulatory Designation
PartnerDrais Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/04/2012

Undisclosed

0

Undisclosed

Get a free BioCentury trial today